← FDA Drug Approvals (Drugs@FDA)

LAMIVUDINE, NEVIRAPINE, AND STAVUDINE

NDA · New Drug Application · Sponsor: HETERO DRUGS LTD · Approved 2010-09-10

Drug application

FDA Application #

NDA200244

Application type

New Drug Application

Brand name

LAMIVUDINE, NEVIRAPINE, AND STAVUDINE

Generic name

Lamivudine

Active ingredients

LAMIVUDINE; NEVIRAPINE; STAVUDINE

Dosage form

TABLET

Route

ORAL

Marketing status

None (Tentative Approval)

Sponsor

HETERO DRUGS LTD

First approval

2010-09-10

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown